Financials
- Market Capitalization 25.75 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry Биотехнологии
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Related tickers
| # | Название | Цена | 24ч % | 7д % | 1М % | 1Г % | Капитализация | Последние 7 дней | |
|---|---|---|---|---|---|---|---|---|---|
| 4480 | NNVC NanoViricides, Inc. Common Stock | 1.24 USD | -3.88% | -5.34% | -20.00% | +22.76% | 26.84 M USD | ||
| 4484 | LTRN Lantern Pharma Inc. - Common Stock | 2.07 USD | -4.17% | -8.81% | -17.53% | -50.60% | 26.46 M USD | ||
| 4497 | EVAX Evaxion A/S - American Depositary Share | 3.01 USD | -4.44% | -9.34% | +7.50% | -9.34% | 25.10 M USD | ||
| 4512 | TVRD Tvardi Therapeutics, Inc. - Common Stock | 1.82 USD | +0.55% | -2.67% | -14.15% | -49.44% | 24.28 M USD |